We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series

This study has been terminated.
(Study terminated due to resources)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00441194
First Posted: February 28, 2007
Last Update Posted: March 5, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Haag Streit USA
  Purpose
To compare the Octopus 311 and the HFA 700 series

Condition Intervention Phase
Visual Field Device: Visual Field (Octopus 311 and the HFA 700 series) Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series With Respect to Reliability, Reproducibility, Test Duration, Patient Preference, Technician Preference.

Further study details as provided by Haag Streit USA:

Estimated Enrollment: 80
Study Start Date: November 2006
Study Completion Date: May 2007
Detailed Description:
To compare the Octopus 311 and the HFA 700 series to evaluate reliability, reproducibility, test duration, patient preference and technician preference.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All subjects
Criteria

Inclusion Criteria:

  • Prior Visual Field

Exclusion Criteria:

  • Scotopic pupil less than 3 mm
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00441194


Locations
United States, Virginia
Capital Eye Consultants
Fairfax, Virginia, United States, 22031
Sponsors and Collaborators
Haag Streit USA
Investigators
Principal Investigator: James Powers, O.D. American, Virginia and Northern Virginia Optometric Associations
  More Information

ClinicalTrials.gov Identifier: NCT00441194     History of Changes
Other Study ID Numbers: HSOCT001
First Submitted: February 27, 2007
First Posted: February 28, 2007
Last Update Posted: March 5, 2012
Last Verified: March 2012

Keywords provided by Haag Streit USA:
Perimetry
Visual Field
Octopus